13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-03-10 Event 2025-03-06 SEC 0000950170-25-036537 →

Whetstone Capital Advisors, LLC OptimizeRx Corp OPRX

Stake: 8.20% Shares: 1,508,303 CUSIP: 68401U204 Class: Common Stock, par value $0.001

Item 4 — Purpose of Transaction

This Amendment hereby amends and supplements Item 4 of the Schedule 13D by inserting the following: On March 6, 2025, WCA provided written notice to the Issuer of its intent to nominate each of Messrs. Andrew Carlson and John Fein for election to the Board at the Issuer's 2025 annual meeting of stockholders. In connection with such notice, the Reporting Persons have communicated, and expect to continue to communicate, with the Issuer about Board composition and other matters. The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, the outcome of the discussions and matters referenced above, actions taken by the Issuer's management or Board, price levels of the Common Stock, liquidity requirements and other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take actions with respect to their investment position in the Issuer as they deem appropriate, including, without limitation, purchasing additional shares of Common Stock or other instruments that are based upon or relate to the value of the Common Stock or the Issuer in the open market or otherwise, selling some or all of the securities reported herein, and/or engaging in hedging or similar transactions with respect to the shares of Common Stock.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 3.53
1,988,505 shares short · +25.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $147K
Point72 Asset Mgmt

Other 13D/G Filings on OptimizeRx Corp

FiledFormFilerStakeShares
2021-04-14 SC CHEZ RONALD L view →
2018-05-10 SC WOLVERINE ASSET MANAGEMENT LLC view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →